Logo for Onego Bio

Meet an Unreasonable Venture

Onego Bio

Disrupting the egg business

Photo of Maija Itkonen

Maija Itkonen

Co-Founder & CEO at Onego Bio

More about Maija »
Employees 21–50
Headquarters Finland
Onego Bio produces Bioalbumen®, a bioidentical, animal-free egg protein made using precision fermentation with the patented Trichoderma reesei fungus. It offers a sustainable, scalable alternative to traditional egg protein for food manufacturers. Operating from Helsinki and San Diego, the company is pre-revenue but has strong interest from major food producers. Long term, Onego Bio aims to scale production, reduce environmental impact, and disrupt the $300 billion egg market.

Notable Achievements

  • Developed a working manufacturing process for non-animal egg protein in just two years.
  • Product Bioalbumen® outperforms traditional egg white powder in third-party tests.
  • Built a world-class team with broad experience that is not reliant on external parties.

Press Mentions

March 28, 2025

Finnish food tech company Onego Bio to invest up to $300 million to build flagship plant in Jefferson

Read on BizTimes - Milwaukee Business News »

More Ventures in Food & Water

Get the Unreasonable Newsletter

Get monthly updates on Onego Bio and all of the other ventures working to solve the world's toughest problems.

Read our Privacy Policy.